Loading Events

« All Events

  • This event has passed.

SATA East Regional Meeting

April 23 @ 8:25 am - 12:45 pm

SATA Regional Meeting Announcement
DMV Liver Transplant Anesthesia Meeting 2022

Meeting: DMV Liver Transplant Anesthesia Meeting 2022
Date: Saturday, April 23rd, 2022
Time: 8:25 AM – 12:45 PM (ET)
Venue: Zoom Virtual

Meeting Chair: 
Lorenzo De Marchi, MD, FASE (MedStar-Georgetown University Hospital)
Completed Program, Registration Information, and CME fee schedule will be sent to you soon. 

Live Virtual Conference (Zoom meeting)

Course Syllabus

Program overview:

This SATA regional meeting provides the audience with updated knowledge on several critical management issues in the liver transplant patients population. 


Learning objectives:

  • Discuss post operative pain management of the donor in a living donor liver transplant (LDLT).
  • Discuss the management of post reperfusion coagulopathy and choice of vasoactive drugs during orthotopic liver transplantation (OLT).
  • Review the pathophysiology and the impact of Cirrhotic Cardiomyopathy and Sickle Cell disease in the liver transplant population.
  • Discuss the surgical criteria for matching candidates to liver transplant and graft.
  • Share the clinical experience in challenging OLT cases.
  • Debate the pros and cons of having a dedicated ICU for liver transplant patients.


Target audience: 

Specialists working in the area of organ transplantation (ex., transplant anesthesiologists, intensivists, transplant surgeons, other transplant medicine specialists, and CRNAs); Trainees (ex., residents, fellows); Students (medical students, nursing students)

Accreditation and CME credit designation: 

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and SATA. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh Medical Center designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™ will be available. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To claim your CME: http://cce.upmc.com

Program committee members: 

  • Lorenzo De Marchi, MD, FASE (MedStar-Georgetown University Hospital)
  • Aliaksei Pustavoitau, MD (Johns Hopkins Hospital)
  • Katherine Forkin, MD (UVA University Hospital)
  • Spencer Liebman, MD (VCU Medical Center)
  • Sergio Navarrete, MD (Johns Hopkins Hospital)
  • Tetsuro Sakai, MD, PhD, MHA (UPMC Medical Center

Platform:  Zoom Webinar (address and password will be provided at the time of registration)

Registration:  https://sata2022.wufoo.com/forms/w1enne17044jtmo/

Registration Fee: 

    • For CME Credit: $30
    • Free if:
      • you are trainees, medical students, or national/international medical personals who do not need CME credits. 
  • lecturers and moderators of the meeting.


Program (EST)

8:25-8:30am  Welcome and Introduction   

Lorenzo De Marchi, MD (MGUH)                 


8:30-9:30am  Session 1: Perioperative Anesthesia 

                          Moderator:  Spencer Liebman, MD (VCU)


LDLT Pain management (Donor) 

     John Burgner, MD (VCU)

Post Reperfusion Coagulopathy 

Julie Huffmyer, MD (UVA)

What vasoactive drug(s) to use during OLT 

Aliaksei Pustavoitau, MD (JHH)


9:30-9:40am       Coffee Break 


9:40-10:40am  Session 2: Multidisciplinary session

Moderator: Sergio Navarrete, MD (JHH)

Cirrhotic cardiomyopathy 

Ilan Wittstein, MD (JHH)


Patient-graft match UVA 

Shawn Pelletier, MD (UVA)

OLT in Sickle Cell patients 

Ahmet Gurakar (JHH)


10:40-10:45am   Break                            


10:45-11:30am Challenging Clinical Cases

Moderator: Katherine Forkin, MD (UVA)


Takotsubo Cardiomyopathy, failure is around the corner

Sam Lawrence, MD (MGUH)


Combined CABG/OLT 

Eryn Thiele, MD (UVA)


OLT in a patient with an acute traumatic intracerebral hemorrhage

Beau Billadeau, MD (VCU)


11:30-12:30pm   PRO/CON Debate: Should we add a “T” before ICU?

Moderator: Aliaksei Pustavoitau, MD (JHH)

PRO: We need a dedicated Transplant ICU 

Megan Rashid, MD (VCU)


CON:  We do NOT need a dedicated Transplant ICU

Benjamin Philosophe, MD (JHH)


12:30-12:45pm Closing remarks 

Tetsuro Sakai, MD, PhD, MHA, FASA (President, SATA) 


Faculty Disclosure

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated:

  • Tetsuro Sakai, MD, PhD, MHA: Springer Inc. (Book royalty), Haemonetics Inc (Grant/Research Support)
  • Aliaksei Pustavoitau, MD: Equity ownership in CoapTech; Stock ownership in GE, Butterfly Network, Sana Biotechnology, Moderna, AstraZeneca, eHealth, and Atea Pharmaceuticals
  • Megan Rashid, MD: Baxter Brazil (Lecturer)

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclaimer Statement

The information presented at this CME program represents the views and opinions of the individual presenters. It does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been made to prepare the educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use their own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions, including, without limitation, FDA-approved uses and any off-label uses.


April 23
8:25 am - 12:45 pm


Lorenzo De Marchi, MD